Revenue

Hedge fund Balyasny Asset Management builds a 1.72% stake in JTC plc, signaling high-stakes maneuvering in the £2.3 billion takeover saga.

A routine filing by hedge fund Balyasny Asset Management may have just put Avadel Pharmaceuticals in the M&A spotlight. Here's what the signal means.

A new book arms working mothers with legal secrets HR won’t share, forcing businesses to rethink their strategic approach to talent and compliance.

Boston's Weiss Asset Management reveals a strategic 4.17% derivative stake in International Personal Finance as a takeover deadline looms.

This REIT's stock is worth millions, but it claims its apartments are worth much more. Can a bold strategic review unlock this hidden value for investors?

A deep dive into Perma-Pipe's record-breaking quarter, revealing a strategy of regional dominance and savvy diversification into high-growth tech sectors.

When a trusted professional evades over $1 million in taxes, the impact goes beyond the courtroom, shaking public trust and starving community services.

GrantWatch founder Libby Hikind is trading grant databases for picture books. Discover the strategy behind her pivot to value-driven children's literature.

A new tech platform is untangling the web of pharmacy sourcing for wellness clinics, promising to slash costs and administrative headaches. Is this the future?

United Imaging Intelligence's new AI agents can reason, act, and report. But are hospitals ready for the business and ethical hurdles of this new era?

Nordic American Tankers is riding a wave of record profits, but the industry's future hinges on volatile markets and the shadow of Venezuelan oil.

Canada Post's 2026 stamp lineup is more than a collection; it's a strategic investment in public health, reconciliation, and community wellness.

Amid a major corporate overhaul, Emergent BioSolutions secures a key FDA approval, signaling a new era for the firm and for U.S. biodefense strategy.

A sustainable energy firm eyes $75M in fees from a $300M Ripple Labs share deal in South Korea. Is this a genius, capital-light move into crypto?

A Chinese environmental giant and a Singaporean robotics upstart join forces. Can their automated solutions really clean up the world's dirtiest jobs?

A top proxy advisory firm urges shareholders to reject Alcon's bid for STAAR Surgical, empowering an activist investor's high-stakes governance fight.

A positive EU opinion for Sobi's Aspaveli could bring the first-ever targeted treatment for two rare kidney diseases, shaking up a market desperate for innovation.

A prestigious TSMC award for Asahi Kasei's PIMEL™ material reveals a critical dependency in the AI chip supply chain and a major strategic bet.

Sidus Space CEO Carol Craig's appointment to the Canaveral Port Authority board signals a new era of synergy between Florida's sea and space industries.

A novel drug for alcohol use disorder gets key scientific backing. It promises the benefits of psychedelics with fewer risks, shaking up a $35B market.